175 related articles for article (PubMed ID: 37093559)
1. Nanoparticle-Based MRI-Guided Tumor Microenvironment Heating via the Synergistic Effect of Ferroptosis and Inhibition of TGF-β Signaling.
Zhou R; Liu Y; Wang Z; Lv J; Liao W; Shen Z; Rong X
Adv Healthc Mater; 2023 Aug; 12(21):e2300176. PubMed ID: 37093559
[TBL] [Abstract][Full Text] [Related]
2. Cycloacceleration of Reactive Oxygen Species Generation Based on Exceedingly Small Magnetic Iron Oxide Nanoparticles for Tumor Ferroptosis Therapy.
Zhou H; Lu X; Du C; Zhou Z; Feng J; Liang Z; Xu Y; Qiu X; Shen Z
Small; 2022 Sep; 18(35):e2202705. PubMed ID: 35923138
[TBL] [Abstract][Full Text] [Related]
3. Fenton-Reaction-Acceleratable Magnetic Nanoparticles for Ferroptosis Therapy of Orthotopic Brain Tumors.
Shen Z; Liu T; Li Y; Lau J; Yang Z; Fan W; Zhou Z; Shi C; Ke C; Bregadze VI; Mandal SK; Liu Y; Li Z; Xue T; Zhu G; Munasinghe J; Niu G; Wu A; Chen X
ACS Nano; 2018 Nov; 12(11):11355-11365. PubMed ID: 30375848
[TBL] [Abstract][Full Text] [Related]
4. Nonferrous Ferroptosis Inducer Manganese Molybdate Nanoparticles to Enhance Tumor Immunotherapy.
Lei H; Li Q; Pei Z; Liu L; Yang N; Cheng L
Small; 2023 Nov; 19(45):e2303438. PubMed ID: 37420331
[TBL] [Abstract][Full Text] [Related]
5. Hierarchically Releasing Bio-Responsive Nanoparticles for Complete Tumor Microenvironment Modulation via TGF-β Pathway Inhibition and TAF Reduction.
Zhang J; Zuo T; Yang J; Hu Z; Wang Z; Xu R; Ma S; Wei Y; Shen Q
ACS Appl Mater Interfaces; 2021 Jan; 13(2):2256-2268. PubMed ID: 33423468
[TBL] [Abstract][Full Text] [Related]
6. A Strategy of Fenton Reaction Cycloacceleration for High-Performance Ferroptosis Therapy Initiated by Tumor Microenvironment Remodeling.
Huang L; Feng J; Zhu J; Yang J; Xiong W; Lu X; Chen S; Yang S; Li Y; Xu Y; Shen Z
Adv Healthc Mater; 2023 Jul; 12(18):e2203362. PubMed ID: 36893770
[TBL] [Abstract][Full Text] [Related]
7. A STING pathway-activatable contrast agent for MRI-guided tumor immunoferroptosis synergistic therapy.
Guo S; Xiong W; Zhu J; Feng J; Zhou R; Fan Q; Zhang Q; Li Z; Yang J; Zhou H; Yi P; Feng Y; Yang S; Qiu X; Xu Y; Shen Z
Biomaterials; 2023 Nov; 302():122300. PubMed ID: 37659110
[TBL] [Abstract][Full Text] [Related]
8. Acidity-Activatable Dynamic Nanoparticles Boosting Ferroptotic Cell Death for Immunotherapy of Cancer.
Song R; Li T; Ye J; Sun F; Hou B; Saeed M; Gao J; Wang Y; Zhu Q; Xu Z; Yu H
Adv Mater; 2021 Aug; 33(31):e2101155. PubMed ID: 34170581
[TBL] [Abstract][Full Text] [Related]
9. Platelet Membrane-Camouflaged Magnetic Nanoparticles for Ferroptosis-Enhanced Cancer Immunotherapy.
Jiang Q; Wang K; Zhang X; Ouyang B; Liu H; Pang Z; Yang W
Small; 2020 Jun; 16(22):e2001704. PubMed ID: 32338436
[TBL] [Abstract][Full Text] [Related]
10. Supramolecularly Engineered Conjugate of Bacteria and Cell Membrane-Coated Magnetic Nanoparticles for Enhanced Ferroptosis and Immunotherapy of Tumors.
Xie B; Zhao H; Ding YF; Wang Z; Gao C; Li S; Zhang K; Ip SW; Yu H; Wang R
Adv Sci (Weinh); 2023 Dec; 10(34):e2304407. PubMed ID: 37850572
[TBL] [Abstract][Full Text] [Related]
11. Multifunctional nanodrug performs sonodynamic therapy and inhibits TGF-β to boost immune response against colorectal cancer and liver metastasis.
Huang S; Ding D; Lan T; He G; Ren J; Liang R; Zhong H; Chen G; Lu X; Shuai X; Wei B
Acta Biomater; 2023 Jul; 164():538-552. PubMed ID: 37037269
[TBL] [Abstract][Full Text] [Related]
12. Heparanase-driven sequential released nanoparticles for ferroptosis and tumor microenvironment modulations synergism in breast cancer therapy.
Zhang J; Yang J; Zuo T; Ma S; Xokrat N; Hu Z; Wang Z; Xu R; Wei Y; Shen Q
Biomaterials; 2021 Jan; 266():120429. PubMed ID: 33035717
[TBL] [Abstract][Full Text] [Related]
13. Blocking LTB
Yan J; Zhu J; Li X; Yang R; Xiao W; Huang C; Zheng C
Phytomedicine; 2023 Oct; 119():154968. PubMed ID: 37531900
[TBL] [Abstract][Full Text] [Related]
14. Combination of oral STING agonist MSA-2 and anti-TGF-β/PD-L1 bispecific antibody YM101: a novel immune cocktail therapy for non-inflamed tumors.
Yi M; Niu M; Wu Y; Ge H; Jiao D; Zhu S; Zhang J; Yan Y; Zhou P; Chu Q; Wu K
J Hematol Oncol; 2022 Oct; 15(1):142. PubMed ID: 36209176
[TBL] [Abstract][Full Text] [Related]
15. A Triple-Responsive Polymeric Prodrug Nanoplatform with Extracellular ROS Consumption and Intracellular H
Li Y; Cao Y; Ma K; Ma R; Zhang M; Guo Y; Song H; Sun N; Zhang Z; Yang W
Adv Healthc Mater; 2024 Feb; ():e2303568. PubMed ID: 38319010
[TBL] [Abstract][Full Text] [Related]
16. Improving function of cytotoxic T-lymphocytes by transforming growth factor-β inhibitor in oral squamous cell carcinoma.
Kondo Y; Suzuki S; Takahara T; Ono S; Goto M; Miyabe S; Sugita Y; Ogawa T; Ito H; Satou A; Tsuzuki T; Yoshikawa K; Ueda R; Nagao T
Cancer Sci; 2021 Oct; 112(10):4037-4049. PubMed ID: 34309966
[TBL] [Abstract][Full Text] [Related]
17. Monitoring ROS Responsive Fe
Zhang L; Qiu M; Wang R; Li S; Liu X; Xu Q; Xiao L; Jiang ZX; Zhou X; Chen S
Angew Chem Int Ed Engl; 2024 May; 63(22):e202403771. PubMed ID: 38551448
[TBL] [Abstract][Full Text] [Related]
18. An injectable and active hydrogel induces mutually enhanced mild magnetic hyperthermia and ferroptosis.
Chen X; Wang H; Shi J; Chen Z; Wang Y; Gu S; Fu Y; Huang J; Ding J; Yu L
Biomaterials; 2023 Jul; 298():122139. PubMed ID: 37148756
[TBL] [Abstract][Full Text] [Related]
19. Local Release of TGF-β Inhibitor Modulates Tumor-Associated Neutrophils and Enhances Pancreatic Cancer Response to Combined Irreversible Electroporation and Immunotherapy.
Peng H; Shen J; Long X; Zhou X; Zhang J; Xu X; Huang T; Xu H; Sun S; Li C; Lei P; Wu H; Zhao J
Adv Sci (Weinh); 2022 Apr; 9(10):e2105240. PubMed ID: 35128843
[TBL] [Abstract][Full Text] [Related]
20. Targeting Ferroptosis-Elicited Inflammation Suppresses Hepatocellular Carcinoma Metastasis and Enhances Sorafenib Efficacy.
Mu M; Huang CX; Qu C; Li PL; Wu XN; Yao W; Shen C; Huang R; Wan CC; Jian ZW; Zheng L; Wu RQ; Lao XM; Kuang DM
Cancer Res; 2024 Mar; 84(6):841-854. PubMed ID: 38231484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
